Zhi-Gang Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Zhi-Gang Yang has a total of 570 co-authors. Here are the top co-authors by number of shared publications:
Ke Shi
Department of Radiology West China Hospital, Sichuan University Chengdu Sichuan China
71 shared publications- Ying-Kun Guo
Department of Radiology, Key Laboratory of Obstetric & Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China
71 shared publications Yuan Li
Department of Radiology, West China Hospital, Sichuan University, Chengdu, China
64 shared publicationsLi Jiang
Department of Radiology West China Hospital, Sichuan University Chengdu Sichuan China
62 shared publicationsYing-Kun Guo
59 shared publicationsYue Gao
Department of Radiology, West China Hospital, Sichuan University
56 shared publications
Latest Publications
- Open Access
- 1 November 2026
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 16 (11) , 843
Mitral regurgitation and left atrial phasic function and atrioventricular coupling in patients with myocardial infarction: a cardiac magnetic resonance imaging study
Background: Mitral regurgitation (MR) after myocardial infarction (MI) may increase left atrial (LA) pressure and contribute to cardiac dysfunction. This study evaluated the incremental association of MR with LA phasic function and strain and identified independent factors associated with LA deformation in patients with MI. Methods: This retrospective study included 189 patients with MI (111 without MR and 78 with MR: mild, 27; moderate, 33; severe, 18) and 86 normal controls who underwent 3.0-T cardiac magnetic resonance (CMR). MR severity was graded by the CMR-derived MR fraction: mild Results: Patients with MI and MR had lower LA reservoir strains [22.14%±10.91% vs. 28.65% (22.78%, 38.30%) vs. 41.70% (36.15%, 53.15%)], booster strains [11.52%±6.19% vs. 13.80% (10.20%, 19.80%) vs. 19.25% (15.10%, 24.05%)], and conduit strains [9.40% (6.03%, 14.85%) vs. 14.60% (9.60%, 20.50%) vs. 22.55% (17.75%, 30.43%)] than patients with MI without MR and controls (all PConclusions: MR was associated with further deterioration of LA myocardial strain in patients with MI. Posteromedial papillary muscle infarction, anterior wall MI, beta-blocker use, and dual antiplatelet therapy with aspirin plus clopidogrel were independently associated with LA strain. CMR-derived functional and strain parameters may help characterize LV-LA coupling and support risk stratification in this population.
- 1 November 2026
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 16 (11) , 843
Open AccessMitral regurgitation and left atrial phasic function and atrioventricular coupling in patients with myocardial infarction: a cardiac magnetic resonance imaging study
Background: Mitral regurgitation (MR) after myocardial infarction (MI) may increase left atrial (LA) pressure and contribute to cardiac dysfunction. This study evaluated the incremental association of MR with LA phasic function and strain and identified independent factors associated with LA deformation in patients with MI. Methods: This retrospective study included 189 patients with MI (111 without MR and 78 with MR: mild, 27; moderate, 33; severe, 18) and 86 normal controls who underwent 3.0-T cardiac magnetic resonance (CMR). MR severity was graded by the CMR-derived MR fraction: mild Results: Patients with MI and MR had lower LA reservoir strains [22.14%±10.91% vs. 28.65% (22.78%, 38.30%) vs. 41.70% (36.15%, 53.15%)], booster strains [11.52%±6.19% vs. 13.80% (10.20%, 19.80%) vs. 19.25% (15.10%, 24.05%)], and conduit strains [9.40% (6.03%, 14.85%) vs. 14.60% (9.60%, 20.50%) vs. 22.55% (17.75%, 30.43%)] than patients with MI without MR and controls (all PConclusions: MR was associated with further deterioration of LA myocardial strain in patients with MI. Posteromedial papillary muscle infarction, anterior wall MI, beta-blocker use, and dual antiplatelet therapy with aspirin plus clopidogrel were independently associated with LA strain. CMR-derived functional and strain parameters may help characterize LV-LA coupling and support risk stratification in this population.
- Open Access
- 7 September 2026
- Published by Wiley in Journal of Magnetic Resonance Imaging
Association Between MRI ‐Derived Right‐to‐Left Ventricular Volume Ratio and Regional Left Ventricular Myocardial Dysfunction in Patients With Pulmonary Arterial Hypertension
Background: Right ventricular (RV) to left ventricular (LV) end‐diastolic volume ratio (RV/LV) is a validated marker of RV dilation in pulmonary arterial hypertension (PAH), yet its impact on LV myocardial function and the underlying mediating pathway is incompletely characterized. Purpose: To investigate the association between RV/LV volume ratio and LV dysfunction in PAH patients, with a focus on regional strain patterns and mediating pathways. Study Type: Retrospective. Population: 188 PAH patients were divided into normal (ratio < 1.27, n = 74) and elevated (ratio ≥ 1.27, n = 114) RV/LV volume ratio groups, and 81 age‐ and sex‐matched controls. Field Strength/Sequence: 3.0‐T/balanced steady‐state free precession cine sequence. Assessment: LV global longitudinal, circumferential, and radial strains (LVGLS, LVGCS, and LVGRS, respectively) and regional strains were measured using feature tracking. Strain parameters were compared among controls and PAH subgroups. Statistical Tests: One‐way ANOVA with Bonferroni‐corrected post hoc tests, Kruskal‐Wallis test, and Pearson or Spearman correlation. Multivariable linear regression was used to identify independent determinants and mediation analysis to examine the mediating pathways. A two‐tailed p < 0.05 was deemed statistically significant. Results: PAH patients with elevated volume ratio had significantly reduced LVGCS and LVGLS. Regional analysis showed that the most extensive strain impairment was at the mid‐ventricular septum. The RV/LV volume ratio was independently associated with LVGCS ( β = −0.194) and LVGLS ( β = −0.307). Mediation analysis demonstrated that the mPAP–LVGLS relationship was statistically mediated by the RV/LV volume ratio, with a significant indirect effect ( β = −0.192, 95% confidence interval: −0.302 to −0.096) and a non‐significant ( p = 0.544) direct effect. Data Conclusion: Elevated RV/LV volume ratio in PAH is associated with spatially heterogeneous LV strain impairment, with the mid‐septum being most vulnerable. The ratio mediates the adverse impact of pulmonary pressure on LV longitudinal strain and may serve as an imaging marker for assessing LV dysfunction. Evidence Level: 3. Technical Efficacy: Stage 3.
- 7 September 2026
- Published by Wiley in Journal of Magnetic Resonance Imaging
Open AccessAssociation Between MRI ‐Derived Right‐to‐Left Ventricular Volume Ratio and Regional Left Ventricular Myocardial Dysfunction in Patients With Pulmonary Arterial Hypertension
Background: Right ventricular (RV) to left ventricular (LV) end‐diastolic volume ratio (RV/LV) is a validated marker of RV dilation in pulmonary arterial hypertension (PAH), yet its impact on LV myocardial function and the underlying mediating pathway is incompletely characterized. Purpose: To investigate the association between RV/LV volume ratio and LV dysfunction in PAH patients, with a focus on regional strain patterns and mediating pathways. Study Type: Retrospective. Population: 188 PAH patients were divided into normal (ratio < 1.27, n = 74) and elevated (ratio ≥ 1.27, n = 114) RV/LV volume ratio groups, and 81 age‐ and sex‐matched controls. Field Strength/Sequence: 3.0‐T/balanced steady‐state free precession cine sequence. Assessment: LV global longitudinal, circumferential, and radial strains (LVGLS, LVGCS, and LVGRS, respectively) and regional strains were measured using feature tracking. Strain parameters were compared among controls and PAH subgroups. Statistical Tests: One‐way ANOVA with Bonferroni‐corrected post hoc tests, Kruskal‐Wallis test, and Pearson or Spearman correlation. Multivariable linear regression was used to identify independent determinants and mediation analysis to examine the mediating pathways. A two‐tailed p < 0.05 was deemed statistically significant. Results: PAH patients with elevated volume ratio had significantly reduced LVGCS and LVGLS. Regional analysis showed that the most extensive strain impairment was at the mid‐ventricular septum. The RV/LV volume ratio was independently associated with LVGCS ( β = −0.194) and LVGLS ( β = −0.307). Mediation analysis demonstrated that the mPAP–LVGLS relationship was statistically mediated by the RV/LV volume ratio, with a significant indirect effect ( β = −0.192, 95% confidence interval: −0.302 to −0.096) and a non‐significant ( p = 0.544) direct effect. Data Conclusion: Elevated RV/LV volume ratio in PAH is associated with spatially heterogeneous LV strain impairment, with the mid‐septum being most vulnerable. The ratio mediates the adverse impact of pulmonary pressure on LV longitudinal strain and may serve as an imaging marker for assessing LV dysfunction. Evidence Level: 3. Technical Efficacy: Stage 3.
- Open Access
- 1 August 2026
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 16 (8) , 637
Association of stress hyperglycemia ratio on right ventricular dysfunction and biventricular coupling in patients with acute coronary syndrome assessed by CMR feature tracking: a cross-sectional study
Background: Among individuals diagnosed with acute coronary syndrome (ACS), the stress hyperglycemia ratio (SHR) has been demonstrated to correlate with an elevated risk of unfavorable cardiovascular events. However, the relationship between SHR, right ventricular (RV) function and biventricular interdependence has not yet been reported. The present study aimed to explore the association of high SHR with RV deformation and biventricular coupling in ACS patients via cardiac magnetic resonance (CMR). Methods: This study consisted of 103 patients with ACS and 57 age- and sex-matched controls. Based on the median of SHR values, ACS patients were stratified into low (Results: ACS patients, irrespective of SHR level, had significantly decreased left ventricular (LV) and RV PS, compared to controls (all P vs. 21.45 (11.02, 28.84)], LV longitudinal PS [−7.92 (−10.77, −6.75) vs. −10.26 (−13.00, −6.34)], RV radial PS [25.03 (18.55, 35.02) vs. 33.31 (20.57, 44.66)], and RV longitudinal PS (−11.92±5.40 vs. −16.60±6.57) than the low-SHR group (all PConclusions: Higher SHR was associated with more impaired RV radial and longitudinal PS in patients with ACS. Exploratory mediation analysis suggested that LV radial and longitudinal PS may partly explain the association between higher SHR and impaired RV radial and longitudinal PS.
- 1 August 2026
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 16 (8) , 637
Open AccessAssociation of stress hyperglycemia ratio on right ventricular dysfunction and biventricular coupling in patients with acute coronary syndrome assessed by CMR feature tracking: a cross-sectional study
Background: Among individuals diagnosed with acute coronary syndrome (ACS), the stress hyperglycemia ratio (SHR) has been demonstrated to correlate with an elevated risk of unfavorable cardiovascular events. However, the relationship between SHR, right ventricular (RV) function and biventricular interdependence has not yet been reported. The present study aimed to explore the association of high SHR with RV deformation and biventricular coupling in ACS patients via cardiac magnetic resonance (CMR). Methods: This study consisted of 103 patients with ACS and 57 age- and sex-matched controls. Based on the median of SHR values, ACS patients were stratified into low (Results: ACS patients, irrespective of SHR level, had significantly decreased left ventricular (LV) and RV PS, compared to controls (all P vs. 21.45 (11.02, 28.84)], LV longitudinal PS [−7.92 (−10.77, −6.75) vs. −10.26 (−13.00, −6.34)], RV radial PS [25.03 (18.55, 35.02) vs. 33.31 (20.57, 44.66)], and RV longitudinal PS (−11.92±5.40 vs. −16.60±6.57) than the low-SHR group (all PConclusions: Higher SHR was associated with more impaired RV radial and longitudinal PS in patients with ACS. Exploratory mediation analysis suggested that LV radial and longitudinal PS may partly explain the association between higher SHR and impaired RV radial and longitudinal PS.
- Open Access
- 26 July 2026
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 25 (1) , 217
Association of the triglyceride-glucose index with subclinical left ventricular dysfunction in type 2 diabetes mellitus: mediation by myocardial energetic efficiency and resting perfusion
- 26 July 2026
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 25 (1) , 217
Open AccessAssociation of the triglyceride-glucose index with subclinical left ventricular dysfunction in type 2 diabetes mellitus: mediation by myocardial energetic efficiency and resting perfusion
- Open Access
- 26 June 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1)
Serial cardiac MR assessment and histopathological evaluation of doxorubicin-induced cardiomyopathy in a miniature swine model
Doxorubicin-induced cardiomyopathy remains challenging to detect at an early stage. This study aims to assess cardiac MR changes and their pathological correlates in a swine model of doxorubicin-induced cardiomyopathy. Miniature pigs received repeated intravenous doxorubicin administration and underwent serial cardiac MR examinations from baseline to 32 weeks. Left ventricular function, global strain, and T2 relaxation time were assessed longitudinally. Histological and ultrastructural analyses were performed at predefined time points to evaluate myocardial injury. LVEF remained relatively preserved during doxorubicin administration and showed only a non-significant declining trend during follow-up. LVGLS showed a non-significant decreasing trend during the treatment (weeks 0-8, P = 0.068) and stabilized during the follow-up period (weeks 8-32, P = 0.35); GCS demonstrated deterioration (week 4: P = 0.006; week 32: P < 0.001); while GRS exhibited significant impairment, with maximal reduction at week 20 (β=-12.87, P = 0.04) that persisted through week 32 (P = 0.001). T2 mapping analysis showed significant elevation during active treatment (χ²=10.5, P = 0.033), followed by partial recovery by the final follow-up (week 32: 36.74 ± 2.80 ms, P = 0.020). Histopathological evaluation demonstrated mitochondrial swelling/vacuolization during treatment, with substantial resolution by week 32. However, persistent abnormalities in myocardial fiber architecture were observed at the study endpoint. In this miniature swine model, T2 prolongation during doxorubicin treatment was temporally associated with mitochondrial-related ultrastructural alterations and may reflect potentially reversible components of myocardial injury. Persistent strain abnormalities despite T2 normalization suggest incomplete structural recovery, mainly reflecting ultrastructural alterations rather than fibrotic progression. Combined T2 mapping and strain assessment may provide complementary information for characterizing doxorubicin-related myocardial injury in preclinical settings.
- 26 June 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1)
Open AccessSerial cardiac MR assessment and histopathological evaluation of doxorubicin-induced cardiomyopathy in a miniature swine model
Doxorubicin-induced cardiomyopathy remains challenging to detect at an early stage. This study aims to assess cardiac MR changes and their pathological correlates in a swine model of doxorubicin-induced cardiomyopathy. Miniature pigs received repeated intravenous doxorubicin administration and underwent serial cardiac MR examinations from baseline to 32 weeks. Left ventricular function, global strain, and T2 relaxation time were assessed longitudinally. Histological and ultrastructural analyses were performed at predefined time points to evaluate myocardial injury. LVEF remained relatively preserved during doxorubicin administration and showed only a non-significant declining trend during follow-up. LVGLS showed a non-significant decreasing trend during the treatment (weeks 0-8, P = 0.068) and stabilized during the follow-up period (weeks 8-32, P = 0.35); GCS demonstrated deterioration (week 4: P = 0.006; week 32: P < 0.001); while GRS exhibited significant impairment, with maximal reduction at week 20 (β=-12.87, P = 0.04) that persisted through week 32 (P = 0.001). T2 mapping analysis showed significant elevation during active treatment (χ²=10.5, P = 0.033), followed by partial recovery by the final follow-up (week 32: 36.74 ± 2.80 ms, P = 0.020). Histopathological evaluation demonstrated mitochondrial swelling/vacuolization during treatment, with substantial resolution by week 32. However, persistent abnormalities in myocardial fiber architecture were observed at the study endpoint. In this miniature swine model, T2 prolongation during doxorubicin treatment was temporally associated with mitochondrial-related ultrastructural alterations and may reflect potentially reversible components of myocardial injury. Persistent strain abnormalities despite T2 normalization suggest incomplete structural recovery, mainly reflecting ultrastructural alterations rather than fibrotic progression. Combined T2 mapping and strain assessment may provide complementary information for characterizing doxorubicin-related myocardial injury in preclinical settings.
- Open Access
- 1 May 2026
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 13, 1787820
Late gadolinium enhancement CMR for detecting myocardial injury after cancer therapy: a real-world observational study
Background: Clinically, cardiotoxicity defined by reduced left ventricle ejection fraction (LVEF) in cancer therapy could miss the onset of tissue-level myocardial changes. In this study, we aimed to use late gadolinium enhancement (LGE) cardiac magnetic resonance (CMR) to evaluate myocardial injury in patients receiving cancer therapy, and to investigate the effect of LGE and other clinical factors on LV function. Methods: This study included 108 cancer patients and 60 healthy controls examined by CMR imaging. Patients were assigned to the LGE-negative (LGE−, n = 80) and LGE-positive groups (LGE+, n = 28). The LV functional parameters and myocardial strain parameters, were compared among the three subgroups. Associations between variables were evaluated via Pearson or Spearman correlation analyses. Further, the association between risk factors and LVEF was determined via multivariate linear regression analysis. Results: The LVEF and peak strain (PS) in all directions were significantly lower in the patients with LGE than in those without (all p < 0.05). There were moderate to high correlations between circumferential peak diastolic strain rate (PDSR), peak systolic strain rate (PSSR), PS, and LVEF in the patients with cancer ( r = 0.54, r = −0.63, r = 0.82, respectively; p < 0.001). Multivariate linear regression analysis revealed independent associations between 1) N-terminal-pro B-type natriuretic peptide and radial, circumferential and longitudinal PS ( β = −0.419, β = 0.407, β = 0.327, respectively; p < 0.001), 2) troponin T and circumferential PDSR ( β = 0.342, p < 0.001) and between 3) the LGE extent (LGE%, 5SD) and circumferential PS ( β = 0.297, p < 0.001). Conclusions: The presence of LGE was an important risk factor for LV dysfunction in patients receiving cancer therapy, and the circumferential strain reduction is the predominant mechanism of LV dysfunction.
- 1 May 2026
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 13, 1787820
Open AccessLate gadolinium enhancement CMR for detecting myocardial injury after cancer therapy: a real-world observational study
Background: Clinically, cardiotoxicity defined by reduced left ventricle ejection fraction (LVEF) in cancer therapy could miss the onset of tissue-level myocardial changes. In this study, we aimed to use late gadolinium enhancement (LGE) cardiac magnetic resonance (CMR) to evaluate myocardial injury in patients receiving cancer therapy, and to investigate the effect of LGE and other clinical factors on LV function. Methods: This study included 108 cancer patients and 60 healthy controls examined by CMR imaging. Patients were assigned to the LGE-negative (LGE−, n = 80) and LGE-positive groups (LGE+, n = 28). The LV functional parameters and myocardial strain parameters, were compared among the three subgroups. Associations between variables were evaluated via Pearson or Spearman correlation analyses. Further, the association between risk factors and LVEF was determined via multivariate linear regression analysis. Results: The LVEF and peak strain (PS) in all directions were significantly lower in the patients with LGE than in those without (all p < 0.05). There were moderate to high correlations between circumferential peak diastolic strain rate (PDSR), peak systolic strain rate (PSSR), PS, and LVEF in the patients with cancer ( r = 0.54, r = −0.63, r = 0.82, respectively; p < 0.001). Multivariate linear regression analysis revealed independent associations between 1) N-terminal-pro B-type natriuretic peptide and radial, circumferential and longitudinal PS ( β = −0.419, β = 0.407, β = 0.327, respectively; p < 0.001), 2) troponin T and circumferential PDSR ( β = 0.342, p < 0.001) and between 3) the LGE extent (LGE%, 5SD) and circumferential PS ( β = 0.297, p < 0.001). Conclusions: The presence of LGE was an important risk factor for LV dysfunction in patients receiving cancer therapy, and the circumferential strain reduction is the predominant mechanism of LV dysfunction.